Clinical Trial Update: Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients [Phase 2]

View source ↗

Summary

Phase 2 trial update on intravenous vitamin C use in allogeneic stem cell transplant recipients, with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoid Leukemia
• Monocytic Leukemia
• Myelodysplasia
• Myeloid Leukemia

Drugs mentioned

• Vitamin C (ascorbic acid)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Lymphoid Leukemia, Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2023-11-07